 Advances understanding treatment urinary tract infections young women relative ease management high rate urinary tract infections UTI young women substantial problems health care community majority UTIs young women simple uncomplicated rate recurrence substantial treatment UTI recurrence brings antibiotic resistance use spectrum expensive antibiotic therapy infection patients underlying urinary tract systemic diseases serious medical financial consequences understanding antibiotic resistance regard beta-lactamase-producing pathogens appropriate criteria antibiotics duration therapy overall cost UTIs young women substantial health care expenditure ongoing examination new information pathogenesis available antibiotic therapies